MARKET

CERT

CERT

Certara, Inc.
NASDAQ
12.18
+1.09
+9.83%
After Hours: 12.00 -0.18 -1.48% 19:52 11/05 EST
OPEN
11.21
PREV CLOSE
11.09
HIGH
12.25
LOW
10.82
VOLUME
3.73M
TURNOVER
--
52 WEEK HIGH
12.25
52 WEEK LOW
4.450
MARKET CAP
1.86B
P/E (TTM)
-27.6128
1D
5D
1M
3M
1Y
5Y
1D
Certara, Inc. Reports Third Quarter 2026 Financial Results and Appoints Chief Product Officer
NASDAQ · 15h ago
Certara price target raised to $12 from $9 at Barclays
TipRanks · 17h ago
Certara price target raised to $12 from $8 at BMO Capital
TipRanks · 18h ago
Certara price target raised to $13 from $11 at Leerink
TipRanks · 18h ago
Certara Q3 2026 Earnings Call Transcript
Benzinga · 22h ago
Certara beats top-line estimates; updates FY26 outlook
Seeking Alpha · 1d ago
Certara Narrows FY2026 Adj EPS Guidance from $0.31-$0.36 to $0.31-$0.34 vs $0.34 Est; Revenue for 2026 FY is expected to be up by 2% to 3% YoY
Benzinga · 1d ago
Certara Q3 2026 Earnings Preview
Seeking Alpha · 1d ago
More
About CERT
Certara, Inc. is a provider of biosimulation science, technology, and consulting services for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical and biotech industry. The Company's proprietary biosimulation platforms are built on biology, chemistry, and pharmacology principles with proprietary mathematical algorithms that model how medicines and diseases behave in the body. It has developed scientifically-based solutions for the collection, standardization, validation, storage, and analysis of the preclinical, clinical and evidence data needed for MIDD. These data solutions are used internally and industry-wide by life sciences companies. The Company applies AI capabilities within established modeling environments and under the supervision of experienced scientists and regulatory experts. Its modeling platforms and curated datasets position it to incorporate emerging AI techniques in a controlled and scientifically rigorous manner.

Webull offers Certara Inc stock information, including NASDAQ: CERT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CERT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CERT stock methods without spending real money on the virtual paper trading platform.